TW200738266A - Pharmaceutical agent containing insulin resistance improving agent - Google Patents
Pharmaceutical agent containing insulin resistance improving agentInfo
- Publication number
- TW200738266A TW200738266A TW095135757A TW95135757A TW200738266A TW 200738266 A TW200738266 A TW 200738266A TW 095135757 A TW095135757 A TW 095135757A TW 95135757 A TW95135757 A TW 95135757A TW 200738266 A TW200738266 A TW 200738266A
- Authority
- TW
- Taiwan
- Prior art keywords
- insulin resistance
- resistance improving
- containing insulin
- agent
- agent containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005283466 | 2005-09-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200738266A true TW200738266A (en) | 2007-10-16 |
Family
ID=37899720
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW095135757A TW200738266A (en) | 2005-09-29 | 2006-09-27 | Pharmaceutical agent containing insulin resistance improving agent |
Country Status (6)
Country | Link |
---|---|
US (1) | US20090124626A1 (zh) |
EP (1) | EP1935432A1 (zh) |
JP (1) | JPWO2007037296A1 (zh) |
CN (1) | CN101277719A (zh) |
TW (1) | TW200738266A (zh) |
WO (1) | WO2007037296A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7820666B2 (en) | 2007-05-08 | 2010-10-26 | Concert Pharmaceuticals, Inc. | Tetrahydrotriazolopyrazine derivatives and uses thereof |
CN101849944A (zh) * | 2009-03-31 | 2010-10-06 | 江苏恒瑞医药股份有限公司 | 治疗2型糖尿病的药物组合物 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR240698A1 (es) * | 1985-01-19 | 1990-09-28 | Takeda Chemical Industries Ltd | Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales |
DE3856378T2 (de) * | 1987-09-04 | 2000-05-11 | Beecham Group Plc | Substituierte Thiazolidindionderivate |
US5594016A (en) * | 1992-12-28 | 1997-01-14 | Mitsubishi Chemical Corporation | Naphthalene derivatives |
IL118474A (en) * | 1995-06-01 | 2001-08-08 | Sankyo Co | Benzimideol derivatives and pharmaceutical preparations containing them |
DE19823831A1 (de) * | 1998-05-28 | 1999-12-02 | Probiodrug Ges Fuer Arzneim | Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen |
CO5150173A1 (es) * | 1998-12-10 | 2002-04-29 | Novartis Ag | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv |
TWI284533B (en) * | 1999-05-24 | 2007-08-01 | Sankyo Co | Pharmaceutical composition for treating hyperglycemia, impaired glucose tolerance, diabetes complications and for improving insulin resistant |
JP2003520226A (ja) * | 2000-01-21 | 2003-07-02 | ノバルティス アクチエンゲゼルシャフト | ジペプチジルペプチダーゼ−iv阻害剤および抗糖尿病薬剤を含む組合せ物 |
US6395767B2 (en) * | 2000-03-10 | 2002-05-28 | Bristol-Myers Squibb Company | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
JP2001315032A (ja) * | 2000-05-08 | 2001-11-13 | Mori Seiki Co Ltd | 工作機械 |
US7078397B2 (en) * | 2000-06-19 | 2006-07-18 | Smithkline Beecham Corporation | Combinations of dipeptidyl peptidase IV inhibitors and other antidiabetic agents for the treatment of diabetes mellitus |
GB0014969D0 (en) * | 2000-06-19 | 2000-08-09 | Smithkline Beecham Plc | Novel method of treatment |
UA74912C2 (en) * | 2001-07-06 | 2006-02-15 | Merck & Co Inc | Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes |
JO2625B1 (en) * | 2003-06-24 | 2011-11-01 | ميرك شارب اند دوم كوربوريشن | Phosphoric acid salts of dipeptidyl betidase inhibitor 4 |
US7671073B2 (en) * | 2004-05-18 | 2010-03-02 | Merck Sharp & Dohme Corp. | Cyclohexylalanine derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
US8017633B2 (en) * | 2005-03-08 | 2011-09-13 | Nycomed Gmbh | Roflumilast for the treatment of diabetes mellitus |
WO2006094942A1 (en) * | 2005-03-08 | 2006-09-14 | Nycomed Gmbh | Roflumilast for the treatment of diabetes mellitus |
-
2006
- 2006-09-27 TW TW095135757A patent/TW200738266A/zh unknown
- 2006-09-28 WO PCT/JP2006/319239 patent/WO2007037296A1/ja active Application Filing
- 2006-09-28 CN CNA2006800349209A patent/CN101277719A/zh active Pending
- 2006-09-28 EP EP06810697A patent/EP1935432A1/en not_active Withdrawn
- 2006-09-28 JP JP2007537655A patent/JPWO2007037296A1/ja active Pending
-
2008
- 2008-03-27 US US12/079,545 patent/US20090124626A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20090124626A1 (en) | 2009-05-14 |
WO2007037296A1 (ja) | 2007-04-05 |
JPWO2007037296A1 (ja) | 2009-04-09 |
CN101277719A (zh) | 2008-10-01 |
EP1935432A1 (en) | 2008-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020009811A (es) | Tratamiento de la diabetes en pacientes con control glucemico insuficiente a pesar de la terapia con un farmaco oral o no oral antidiabetico. | |
HUE043823T2 (hu) | Fecskendõk, fecskendõ csatlakozások és fecskendõ dugattyúk orvosi injektorokkal való alkalmazásra | |
WO2007146426A3 (en) | Nanoshells for drug delivery | |
IL160420A0 (en) | Treating or preventing diabetes with cannabidiol | |
UA87334C2 (ru) | Приводной механизм для применения в устройстве введения лекарств, устройство введения лекарств, применение приводного механизма (варианты) и способ сборки устройства введения лекарств | |
EP1611880A3 (en) | Pharmaceutical formulations for the safe administration of drugs used in the treatment of drug addiction | |
EP1799285A4 (en) | SPRAYING DEVICES AND METHOD FOR MIXING AND DISPERSING MEDICAMENTS | |
EP2036574A4 (en) | MEDICAL AGENT FOR THE TREATMENT OF FAT, DIABETES AND DISEASES IN CONNECTION WITH IMPROVED GLUCOSE TOLERANCE | |
AU2007221366A8 (en) | Oxyntomodulin derivatives | |
MY145590A (en) | Phenylacetamides and their use as glucokinase modulators | |
TW200604179A (en) | Pyrazole derivatives, compositions containing such compounds and methods of use | |
WO2007079146A8 (en) | Treatment for non-hodgkin's lymphoma | |
EP1948273A4 (en) | SYRINGE GUARD FOR PRE-FILLED MEDICINAL FLASK | |
WO2007079171A3 (en) | Treatment for hodgkin's lymphoma | |
MX347372B (es) | Uso de metformina en combinacion con un activador de glucoquinasa y composiciones que comprenden metformina y un activador de glucoquinasa. | |
TW200745044A (en) | Pyrazole derivatives, compositions containing such compounds and methods of use | |
WO2004050115A3 (en) | Combination treatment using exendin-4 and thiazolidinediones | |
TN2009000119A1 (en) | Combination drug | |
IL171911A0 (en) | Catheter for uniform delivery of medication | |
TW200738266A (en) | Pharmaceutical agent containing insulin resistance improving agent | |
TW200633720A (en) | Medicinal composition for diabetic | |
GB0606001D0 (en) | Combination Of Cicletanine And An Oral Antidiabetic And/Or Blood Lipid-Lowering Agent For Treating Diabetes And Metabolic Syndrome | |
EP2009443A4 (en) | DIAGNOSTIC AND THERAPEUTIC AGAINST PANCREAS CANCER | |
GB0313386D0 (en) | Treatment of disease | |
TNSN07273A1 (en) | Methods of use of dual ppar agonist compounds and drug delivery devices containing such compounds |